Analysis of efficacy of SGLT2 inhibitors using semi-mechanistic model

• मुख्य लेखकों: Oleg eDemin Jr (लेखक), Tatiana eYakovleva (लेखक), Dmitry eKolobkov (लेखक), Oleg eDemin (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2014-10-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Renal sodium-dependent glucose co-transporter 2 (SGLT2) is one of the most promising targets for the treatment of type 2 diabetes. Two SGLT2 inhibitors, dapagliflozin and canagliflozin, have already been approved for use in USA and Europe; several additional compounds are also being developed for th...